Mizuho Reiterates "Buy" Rating for LivaNova (NASDAQ:LIVN)Zolmax • 27 days ago
LivaNova (NASDAQ:LIVN Get Free Report)s stock had its buy rating restated by stock analysts at Mizuho in a report released on Wednesday, Benzinga reports. They presently...
Share to Feed
Shares of LivaNova PLC (NASDAQ:LIVN Get Free Report) saw an uptick in trading volume on Wednesday . 296,173 shares were traded during mid-day trading, a decline of 49% from the previous...
This is a Bullish indicator signaling LIVN's price could rise from here. Traders may explore going long the stock or buying call options...
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, will host a conference call to discuss its first-quarter 2024 results on Wednesday, May 1, 2024 at 1 p.m. London time (8 a.m...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
LivaNova PLC (NASDAQ:LIVN Get Free Report) saw unusually-high trading volume on Wednesday . Approximately 296,173 shares changed hands during mid-day trading, a decline of 49% from the...
Check out David Einhorn Stock Picks »
Download GuruFolio Report of David Einhorn (Updated on 03/19/2024), Check out PRIMECAP Management Stock Picks »
Download GuruFolio Report of...
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced its OSPREY clinical study, Treating Obstructive Sleep Apnea Using Targeted Hypoglossal Nerve Stimulation, has...
Tudor Investment Corp Et Al cut its stake in shares of LivaNova PLC (NASDAQ:LIVN Free Report) by 60.0% during the 3rd quarter, according to its most recent 13F filing with the Securities and...
In trading on Thursday, shares of LivaNova PLC (LIVN) crossed below their 200 day moving average of 51.18, changing hands as low as 51.12 per share. LivaNova PLC shares are currently...